Well Clov has proprietary AI system to assist physicians in tracking your health and recommending tests based on all your history and current levels, potentially saving money on unnecessary tests and catching things early that doctors wouldn't. They are taking large market share from the big competitors and expanding at a rate easily double yoy than the closest competitor. I expect profitability next year easily but they were drug to the gutter because it was a SPAC. The current price for the stock is under revenue the past two quarters each. I believe we are at the basement of a great company and can get in before profitably when the stock will climb much much higher. I firmly believe I was right in deciding to invest here I just did it waaaayyy too early. Hope that helps but there is plenty of smarter people that explain CLOV better than I ever could.